Drawing for Serial No. 79287972

USPTO serial 79287972

Serial No. 79287972

Reviewed by CopyMark Law Group

Reg. 7191308Status 404
Filing date
Status date
Registration date
Oct 17, 2023
Examiner
GLASSER, CARYN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 79287972?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 BENSON DRRALEIGH, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; anti-inflammatories; antibacterial pharmaceutical products; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the central nervous system; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the treatment of eye diseases and pathologies; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for the treatment of skin conditions; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for treating respiratory diseases; pharmaceutical products for treating respiratory diseases and asthmaSECTION 70 - CANCELLED—
044Medical services, namely, medical information provided to patients and health care professionalsSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 9, 2024DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Sep 9, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Feb 5, 2024FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 17, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 17, 2024FIMPFINAL DISPOSITION PROCESSED—
Jan 17, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 17, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 17, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 1, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 1, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 31, 2023GPNXNOTIFICATION PROCESSED BY IB—
Jul 12, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 12, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 12, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 27, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Feb 24, 2022FINAFINAL DISPOSITION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Feb 24, 2022CREVCORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED—
Jan 26, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 26, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 20, 2022CRTPREG. CANCELLED - RESTORED TO PENDENCY—
Jan 7, 2022APETASSIGNED TO PETITION STAFF—
Jan 7, 2022RCIIREQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED—
Mar 15, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 15, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 29, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 29, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 9, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 5, 2020RFNTREFUSAL PROCESSED BY IB—
Aug 21, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 20, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 20, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 20, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 14, 2020CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Aug 11, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 11, 2020RFRRREFUSAL PROCESSED BY MPU—
Jul 31, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 31, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 31, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 31, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 31, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 31, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 21, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 20, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 15, 2020DOCKASSIGNED TO EXAMINER—
Jul 14, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 10, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 2, 2020LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jun 18, 2020SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance